Table of Contents
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 Oncology
1.2.1.2 Infectious Diseases
1.2.1.3 Rare Diseases
1.2.1.4 Autoimmune Diseases
1.2.1.5 Pulmonary Diseases
1.2.1.6 Neurological Disorders
1.2.1.7 Others
1.2.2 by Application
1.2.2.1 Hospital
1.2.2.2 Clinic
1.2.2.3 Research Institute
1.2.2.4 Laboratories
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Oncology Market, 2013-2018
4.1.2 Infectious Diseases Market, 2013-2018
4.1.3 Rare Diseases Market, 2013-2018
4.1.4 Autoimmune Diseases Market, 2013-2018
4.1.5 Pulmonary Diseases Market, 2013-2018
4.1.6 Neurological Disorders Market, 2013-2018
4.1.7 Others Market, 2013-2018
4.2 Market Forecast
4.2.1 Oncology Market Forecast, 2019-2024
4.2.2 Infectious Diseases Market Forecast, 2019-2024
4.2.3 Rare Diseases Market Forecast, 2019-2024
4.2.4 Autoimmune Diseases Market Forecast, 2019-2024
4.2.5 Pulmonary Diseases Market Forecast, 2019-2024
4.2.6 Neurological Disorders Market Forecast, 2019-2024
4.2.7 Others Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Market, 2013-2018
5.1.2 Clinic Market, 2013-2018
5.1.3 Research Institute Market, 2013-2018
5.1.4 Laboratories Market, 2013-2018
5.2 Market Forecast
5.2.1 Hospital Market Forecast, 2019-2024
5.2.2 Clinic Market Forecast, 2019-2024
5.2.3 Research Institute Market Forecast, 2019-2024
5.2.4 Laboratories Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 Roche
8.2 Abbvie
8.3 Novartis International AG
8.4 Janssen
8.5 BMS
8.6 Eli Lilly
8.7 Gilead
8.8 Sanofi
8.9 Regeneron
8.10 Acadia
8.11 Boehringer Ingelheim
8.12 Amgen
8.13 AstraZeneca
8.14 GlaxoSmithKline
8.15 Vertex
8.16 Alexion
8.17 Merck
8.18 Jazz Pharmaceuticals
8.19 Exelixis
8.20 Eisai
8.21 Takeda
8.22 Pfizer
9 Conclusion
Table Product Specifications of Breakthrough Therapy (BT) Designation
Table Products Segment of Breakthrough Therapy (BT) Designation
Table Oncology Overview
Table Infectious Diseases Overview
Table Rare Diseases Overview
Table Autoimmune Diseases Overview
Table Pulmonary Diseases Overview
Table Neurological Disorders Overview
Table Others Overview
Table Global Breakthrough Therapy (BT) Designation Market by Type, 2011-2022 (USD Million)
Table Application Segment of Breakthrough Therapy (BT) Designation
Table Hospital Overview
Table Clinic Overview
Table Research Institute Overview
Table Laboratories Overview
Table Global Breakthrough Therapy (BT) Designation Market by Application, 2011-2022 (USD Million)
Table Global Breakthrough Therapy (BT) Designation Market by Region, 2011-2022 (USD Million)
Table Cost of Breakthrough Therapy (BT) Designation
Table Market Dynamics
Table Policy of Breakthrough Therapy (BT) Designation
Table GDP of Major Countries
Table Oncology CAGR by Revenue and Volume, 2012-2018
Table Infectious Diseases CAGR by Revenue and Volume, 2012-2018
Table Rare Diseases CAGR by Revenue and Volume, 2012-2018
Table Autoimmune Diseases CAGR by Revenue and Volume, 2012-2018
Table Pulmonary Diseases CAGR by Revenue and Volume, 2012-2018
Table Neurological Disorders CAGR by Revenue and Volume, 2012-2018
Table Others CAGR by Revenue and Volume, 2012-2018
Table Oncology CAGR by Revenue and Volume, 2012-2024
Table Infectious Diseases CAGR by Revenue and Volume, 2012-2024
Table Rare Diseases CAGR by Revenue and Volume, 2012-2024
Table Autoimmune Diseases CAGR by Revenue and Volume, 2012-2024
Table Pulmonary Diseases CAGR by Revenue and Volume, 2012-2024
Table Neurological Disorders CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Hospital CAGR by Revenue and Volume, 2012-2018
Table Clinic CAGR by Revenue and Volume, 2012-2018
Table Research Institute CAGR by Revenue and Volume, 2012-2018
Table Laboratories CAGR by Revenue and Volume, 2012-2018
Table Global Breakthrough Therapy (BT) Designation Market by Vendors, 2012-2018 (USD Million)
Table Global Breakthrough Therapy (BT) Designation Market by Vendors, 2012-2018 (in Volume)
Table Global Breakthrough Therapy (BT) Designation Market Share by Vendors, 2012-2018 (USD Million)
Table Global Breakthrough Therapy (BT) Designation Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Abbvie Profile List
Table Microecological Modulator Operating Data of Abbvie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis International AG Profile List
Table Microecological Modulator Operating Data of Novartis International AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Janssen Profile List
Table Microecological Modulator Operating Data of Janssen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table BMS Profile List
Table Microecological Modulator Operating Data of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eli Lilly Profile List
Table Microecological Modulator Operating Data of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Gilead Profile List
Table Microecological Modulator Operating Data of Gilead (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofi Profile List
Table Microecological Modulator Operating Data of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Regeneron Profile List
Table Microecological Modulator Operating Data of Regeneron (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Acadia Profile List
Table Microecological Modulator Operating Data of Acadia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Profile List
Table Microecological Modulator Operating Data of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Profile List
Table Microecological Modulator Operating Data of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AstraZeneca Profile List
Table Microecological Modulator Operating Data of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GlaxoSmithKline Profile List
Table Microecological Modulator Operating Data of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Vertex Profile List
Table Microecological Modulator Operating Data of Vertex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Alexion Profile List
Table Microecological Modulator Operating Data of Alexion (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Jazz Pharmaceuticals Profile List
Table Microecological Modulator Operating Data of Jazz Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Exelixis Profile List
Table Microecological Modulator Operating Data of Exelixis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Eisai Profile List
Table Microecological Modulator Operating Data of Eisai (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Takeda Profile List
Table Microecological Modulator Operating Data of Takeda (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Figure Breakthrough Therapy (BT) Designation Picture
Figure Industry Chain Structure of Breakthrough Therapy (BT) Designation
Figure SWOT of Breakthrough Therapy (BT) Designation
Figure Oncology Market Size and Growth, 2012-2018 (USD Million)
Figure Oncology Market Size and Growth, 2012-2018 (in Volume)
Figure Infectious Diseases Market Size and Growth, 2012-2018 (USD Million)
Figure Infectious Diseases Market Size and Growth, 2012-2018 (in Volume)
Figure Rare Diseases Market Size and Growth, 2012-2018 (USD Million)
Figure Rare Diseases Market Size and Growth, 2012-2018 (in Volume)
Figure Autoimmune Diseases Market Size and Growth, 2012-2018 (USD Million)
Figure Autoimmune Diseases Market Size and Growth, 2012-2018 (in Volume)
Figure Pulmonary Diseases Market Size and Growth, 2012-2018 (USD Million)
Figure Pulmonary Diseases Market Size and Growth, 2012-2018 (in Volume)
Figure Neurological Disorders Market Size and Growth, 2012-2018 (USD Million)
Figure Neurological Disorders Market Size and Growth, 2012-2018 (in Volume)
Figure Others Market Size and Growth, 2012-2018 (USD Million)
Figure Others Market Size and Growth, 2012-2018 (in Volume)
Figure Oncology Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Oncology Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Infectious Diseases Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Infectious Diseases Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Rare Diseases Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Rare Diseases Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Autoimmune Diseases Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Autoimmune Diseases Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Pulmonary Diseases Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Pulmonary Diseases Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Neurological Disorders Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Neurological Disorders Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Others Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Others Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Hospital Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Clinic Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Research Institute Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Laboratories Market Size and Growth, 2012-2018 (USD Million)
Figure Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2012-2018 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2012-2018 (USD Million)
Figure North America Market Size and Growth, 2012-2018 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2012-2018 (USD Million)
Figure Europe Market Size and Growth, 2012-2018 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2012-2018 (USD Million)
Figure South America Market Size and Growth, 2012-2018 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2012-2018 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2012-2018 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure North America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure North America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Europe Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Europe Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure South America Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure South America Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2019-2024 (in Volume)
Figure Breakthrough Therapy (BT) Designation Market Concentration by Region
Figure Marketing Channels Overview
